Metabolic syndrome in adult patients with Prader-Willi syndrome

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 11, 2013, Pages 1134-1140

  Grugni, G ^a   Crino A ^b   Bedogni, G ^c   Cappa, M ^b   Sartorio, A ^a   Corrias, A ^d   Di Candia, S ^e   Gargantini, L ^f   Iughetti, L ^g   Pagano, C ^h   Ragusa, L ⁱ   Salvatoni, A ^j   Spera, S ^b   Vettor, R ^h   Chiumello, G ^e   Brambilla, P ^k  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c Liver Research Center   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f Civic Hospital of Treviglio   (Italy)

^g UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ OASI RESEARCH INSTITUTE IRCCS   (Italy)

^j UNIVERSITY OF INSUBRIA   (Italy)

^k ASL Milano 2   (Italy)

more..

Author keywords

BMI; BP; DELETED; HDL C; HOMA index; Hypertension; Insulin; Lipids; Metabolic syndrome; MetS; Obesity; Prader Willi syndrome; PWS; T2DM; UPD15; WC

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; METFORMIN; NEUROLEPTIC AGENT; SEX HORMONE; THYROXINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BEHAVIOR DISORDER; BODY MASS; CHEMOLUMINESCENCE; CHROMOSOME 15; CHROMOSOME DELETION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DNA METHYLATION; FEMALE; HOMEOSTASIS; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRADER WILLI SYNDROME; PREVALENCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

BLOOD PRESSURE; BMI; BODY MASS INDEX; BP; DELETED; HDL-C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMA-INDEX; HOMEOSTASIS MODEL ASSESSMENT INDEX; HYPERTENSION; INSULIN; INTERSTITIAL DELETION OF THE PROXIMAL LONG ARM OF CHROMOSOME 15 (DEL15Q11-Q13); LIPIDS; METABOLIC SYNDROME; METS; OBESITY; PRADER-WILLI SYNDROME; PWS; T2DM; TYPE 2 DIABETES MELLITUS; UNIPARENTAL MATERNAL DISOMY FOR CHROMOSOME 15; UPD15; WAIST CIRCUMFERENCE; WC;

ADOLESCENT; ADULT; BODY MASS INDEX; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 15; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; ITALY; MALE; MATCHED-PAIR ANALYSIS; METABOLIC SYNDROME X; OBESITY; PRADER-WILLI SYNDROME; PREVALENCE; RISK; TRANSLOCATION, GENETIC; UNIPARENTAL DISOMY; YOUNG ADULT;

EID: 84887610381     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2012.11.006     Document Type: Article

References (35)

1. Bittel D.C., Butler M.G. Prader-Willi syndrome. Clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med 2005, 7:1-20.
2. Vogels A., Van Den Ende J., Keymolen K., Mortier G., Devriendt K., Legius E., et al. Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders. Eur J Med Genet 2004, 12:238-240.
3. Cassidy S.B., Driscoll D.J. Prader-Willi syndrome. Eur J Hum Genet 2009, 17:3-13.
4. Burman P., Ritzen E.M., Lindgren A.C. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev 2001, 22:787-799.
5. Brambilla P., Bosio L., Manzoni P., Pietrobelli A., Beccaria L., Chiumello G. Peculiar body composition in patients with Prader-Labhart-Willi. Am J Clin Nutr 1997, 65:1369-1374.
6. Whittington J.E., Holland A.J., Webb T., Butler J., Clarke D., Boer H. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet 2001, 38:792-798.
7. Butler M.G., Hanchett J.M., Thompson T. Clinical findings and natural history of Prader-Willi syndrome. Management of Prader-Willi syndrome 2006, 3-48. Springer, New York. 3rd ed. M.G. Butler, P.D.K. Lee, B.Y. Whitman (Eds.).
8. Mottillo S., Filio K.B., Genest J., Joseph L., Pilote L., Poirier P., et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. Am J Coll Cardiol 2010, 56:1113-1132.
9. Talebizadeh Z., Butler M.G. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects. Clin Genet 2004, 67:230-239.
10. Goldstone A.P., Thomas E.L., Brynes A.E., Bell J.D., Frost G., Saeed N., et al. Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab 2001, 86:4330-4338.
11. Marzullo P., Marcassa C., Campini R., Eleuteri E., Minocci A., Priano L., et al. The impact of growth hormone/insulin-like growth factor-1 and nocturnal breathing disorders on cardiovascular features of adult patients with Prader-Willi syndrome. J Clin Endocrinol Metab 2005, 90:5639-5646.
12. Patel S., Harmer J.A., Loughnan G., Skilton M.R., Steinbeck K., Celermajer D.S. Characteristics of cardiac and vascular structure and function in Prader-Willi syndrome. Clin Endocrinol 2007, 66:771-777.
13. l'Allemand D., Eiholzer U., Schumpf M., Steinert H., Riesen W. Cardiovascular risk factors improve during 3 years of growth hormone therapy in Prader-Willi syndrome. Eur J Pediatr 2000, 159:835-842.
14. Brambilla P., Crinò A., Bedogni G., Bosio L., Cappa M., Corrias A., et al. Metabolic syndrome in children with Prader-Willi syndrome: the effect of obesity. Nutr Metab Cardiovasc Dis 2011, 21:269-276.
15. Holm V.A., Cassidy S.B., Butler M.G., Hanchett J.M., Greenswag L.R., Whitman B.Y., et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993, 91:398-402.
16. Chotai K.A., Payne S.J. A rapid, PCR based test for differential molecular diagnosis of Prader-Willi and Angelman syndromes. J Med Genet 1998, 35:472-475.
17. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
18. Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
19. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
20. Bruce K.D., Hanson M.A. The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr 2010, 140:648-652.
21. Zipf M.B. Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy. Acta Paediatr Suppl 1999, 88:115-117.
22. Lamb A.S., Johnson W.M. Premature coronary artery atherosclerosis in a patient with Prader-Willi syndrome. Am J Med Genet 1987, 28:873-880.
23. Page S.R., Nussey S.S., Haywood G.A., Jenkins J.S. Premature coronary artery disease and the Prader-Willi syndrome. Postgrad Med J 1990, 66:232-234.
24. Butler J.V., Whittington J.E., Holland A.J., Boer H., Clarke D., Webb T. Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol 2002, 44:248-255.
25. Hoybye C. Inflammatory markers in adults with Prader-Willi syndrome before and during 12 months growth hormone treatment. Horm Res 2006, 66:27-32.
26. Zalesin K.C., Franklin B.A., Miller W.M., Peterson E.D., McCullough P.A. Impact of obesity on cardiovascular disease. Med Clin North Am 2011, 95:919-937.
27. Theodoro M.F., Talebizadeh Z., Butler M.G. Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity. Obesity 2006, 14:1685-1690.
28. Park Y.-W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., Heymsfield S.B. The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the Third National Health And Nutrition Examination Survey 1988-1994. Arch Intern Med 2003, 163:427-436.
29. Krochik A.G., Ozuna B., Torrado M., Chertkoff L., Mazza C. Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab 2006, 19:911-918.
30. Haqq A.M., Muehlbauer M.J., Newgard C.B., Grambow S., Freemark M. The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. J Clin Endocrinol Metab 2011, 96:E225-E232.
31. Hoybye C., Hilding A., Jacobsson H., Thoren M. Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity. J Clin Endocrinol Metab 2002, 87:3590-3597.
32. Kennedy L., Bittel D.C., Kibiryeva N., Kalra S.P., Torto R., Butler M.G. Circulating adiponectin levels, body composition, and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects. Int J Obes 2006, 30:382-387.
33. Sode-Carlsen R., Farholt S., Rabben K.F., Bollerslev J., Schreiner T., Jurik A.G., et al. Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome. Growth Horm IGF Res 2010, 20:179-184.
34. Purtell L., Sze L., Loughnan G., Smith E., Herzog H., Sainsbury A., et al. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels. Neuropeptides 2011, 45:301-307.
35. Butler M.G., Bittel D.C., Kibiryeva N., Garg U. C-reactive protein levels in subjects with Prader-Willi syndrome and obesity. Genet Med 2006, 8:243-248.